India is rapidly establishing itself as a global hub for neutraceutical active pharmaceutical ingredient production, driven by a combination of factors including competitive rates, a skilled labor pool, and supportive government regulations. Numerous businesses are now focusing on the synthesis and provision of these crucial ingredients used in die